CBRN Decontamination Industry Outlook - 2007-2012

SUMMARY

This report describes existing and upcoming technologies, markets, business and funding opportunities related to producing, using, and/or stockpiling Chemical, Biological, Nuclear and Radiological (CBRN) decontamination equipment and material for the purpose of decontaminating people, as well as indoor and outdoor environments.

The research answers, among others, the following questions:

• What are the main drivers and inhibitors relevant to existing decontamination technologies and markets?
• What are the business opportunities that arise from the distance between existing technologies and products and the technologies and products required to provide needed protection?
• Who, in government, is involved with decontamination R&D, and what is the funding opportunities horizon through the end of the decade and the start of the next decade?

The systems reviewed in this report include the following modalities:

• Personnel decontamination systems
• Equipment decontamination systems
• Infrastructure and Building decontamination systems
• Environmental decontamination systems

TABLE OF CONTENTS

1. Scope

• 1.1. Definition of Decontamination
• 1.2. Scope of this Report
• 1.3. Basic Assumptions
  • 1.3.1. General
  • 1.3.2. Why is Stockpiling Decontamination Solutions Needed?
  • 1.3.3. Possible Scenario Analysis
• 1.4. Methodology
  • 1.4.1. Research Methods
  • 1.4.2. Report Structure
• 1.5. Who is this Report for?

2. Executive Summary

• 2.1. Main Conclusions
• 2.2. The Threat of CBRN Terrorism
• 2.3. How Real is the Threat?
• 2.4. Decontaminating After a CBRN Event
• 2.5. Decontamination - the Industry
• 2.6. Decontamination Market Forecast - 2007-2012
• 2.7. Challenges for Next Generation Decontamination Technologies

3. Decontamination - Industry Drivers

4. Decontamination - Industry Inhibitors

5. The Threat of CBRN Warfare

• 5.1. The Threat of Biological Terror
  • 5.1.1. Use of Bio-Weapons - Historical Perspective
  • 5.1.2. Biological Terror - Bacterial Agents
  • 5.1.3. Biological Terror - Viral Agents
  • 5.1.4. Biological Terror - Rickettsiae Agents
  • 5.1.5. Biological Terror - Toxins
• 5.2. The Threat of Nuclear Radiological Terror
  • 5.2.1. How Real is the Nuclear Threat?
  • 5.2.2. Nuclear Terror
  • 5.2.3. A Radiological Dispersal Device (RDD)
• 5.3. The Threat of Chemical Terror
  • 5.3.1. Nerve Agents
  • 5.3.2. Blister Agents

6. Decontamination - Technological and System Requirements

• 6.1. Defining the Problem
• 6.2. Stages of a Decontamination Process
  • 6.2.1. Contaminant Identification
  • 6.2.2. Sample Characterization
  • 6.2.3. Isolation of Contaminated Area
  • 6.2.4. Design of Decontamination Strategy
  • 6.2.5. Decontamination
  • 6.2.6. Clearance Sampling
• 6.3. Performance Limitations
  • 6.3.1. Limit 1 - Time
  • 6.3.2. Limit 2 - How Clean is Clean
  • 6.3.3. Limit 3 - Lack of Accurate Contamination Simulations Scenarios
  • 6.3.4. Limit 4 - Cost
  • 6.3.5. Limit 5 - Environmentally Unfriendly Materials
  • 6.3.6. Limit 6 - Transport and Storage Limitations
  • 6.3.7. Limit 7 - Inability to Handle Radioactive Contamination
• 6.4. Decontamination Core Technologies Overview
• 6.5. Physics-Based Decontamination Core Technologies
  • 6.5.1. Sorbents
  • 6.5.2. Solvent-Wash
  • 6.5.3. High-Pressure Methods
  • 6.5.4. Thermal Methods
• 6.6. Chemistry-based Decontamination Core Technologies
  • 6.6.1. Oxidizing Agents
  • 6.6.2. Strong Bases
  • 6.6.3. Surfactants
  • 6.6.4. Microemulsions
• 6.7. Biology-Based Core Technologies
  • 6.7.1. Bacterial Decontamination Agents
  • 6.7.2. Enzymatic Systems
• 6.8. Decontamination System Configurations
  • 6.8.1. Application 1 - People Decontamination Systems
  • 6.8.2. Application 2 - Equipment Decontamination Systems
  • 6.8.3. Application 3 - Building and Infrastructure Decontamination Systems
• 6.9. New Technologies Drivers
• 6.10. New Technologies Inhibitors

7.Business Opportunities - 2007-2012

• 7.1. Historical Perspective: A Market Waiting for Transition
  • 7.1.1. The Current and Future HLS Decontamination Strategy
  • 7.1.2. Factors Affecting Decontamination Systems Business Opportunities and Technologies - 2007-2012
• 7.2. Business Opportunities for Decontamination Systems
  • 7.2.1. Business Opportunity 1 - New Technologies to Counter Radiological Contamination
  • 7.2.2. Business Opportunity 2 - Non-Toxic/Environmentally Friendly Biological-Agents Decontamination Technology
  • 7.2.3. Business Opportunity 3 - Improving Contamination Simulation Capability
  • 7.2.4. Business Opportunity 4 - Improving Biological Sampling Accuracy
  • 7.2.5. Business Opportunity 5 - Decontamination Standards
  • 7.2.6. Business Opportunity 6 - Reducing Decontamination Time
  • 7.2.7. Business Opportunity 7 - Reducing Cost of Reagents / Decontamination Material
• 7.3. Radiological Decontamination Technologies
  • 7.3.1. Business Opportunity 8 - Concrete-Eating Bacteria
  • 7.3.2. Business Opportunity 9 - Decontamination Foams
  • 7.3.3. Business Opportunity 10 - Nano-Particle Super-Absorbent Gels
  • 7.3.4. Business Opportunity 11 - Strippable coatings
  • 7.3.5. Business Opportunity 12 - Electro-Kinetic Concrete Cleaning
• 7.4. Chemical-Biological Decontamination Technologies and Business Opportunities
  • 7.4.1. Business Opportunity 13 - Forced Hot Air Systems
  • 7.4.2. Business Opportunity 14 - Modified Vaporous Hydrogen Peroxide
  • 7.4.3. Business Opportunity 15 - Decon Green
  • 7.4.4. Business Opportunity 16 - Resistant/Reactive Coatings
  • 7.4.5. Business Opportunity 17 - Enzyme Decontamination
  • 7.4.6. Business Opportunity 18 - Ionic-Liquid-based Decontamination
  • 7.4.7. Business Opportunity 19 - Supercritical Carbon Dioxide Decontamination
  • 7.4.8. Business Opportunity 20 - Electrostatic Decontamination System
  • 7.4.9. Business Opportunity 21 - Atmospheric Plasma Decontamination
• 7.5. Contamination Simulation Algorithms
  • 7.5.1. Business Opportunity 22 - Vulnerability of Building to CBRN Attack Algorithms

8. Decontamination - U. S. Federal HLS R&D Programs and Funding Opportunities Forecast - 2007-2012

• 8.1. Summary & Outlook
• 8.2. Decontamination - U. S. Federal HLS R&D Funding Opportunities by Major Departments Forecast - 2007-2012
  • 8.2.1. EPA - Decontamination HLS R&D Budget Forecast - 2007-2012
  • 8.2.2. DOD - Decontamination HLS R&D Budget Forecast - 2007-2012
  • 8.2.3. DHS - Decontamination HLS R&D Budget Forecast - 2007-2012
  • 8.2.4. DOE - Decontamination HLS R&D Budget Forecast - 2007-2012
  • 8.2.5. TSWG - Decontamination HLS R&D Budget Forecast - 2007-2012
• 8.3. Decontamination - U. S. Federal HLS R&D Funding Opportunities Forecast - 2007-2012
• 8.4. Decontamination - U. S. Federal HLS Pharmaceuticals R&D Funding Opportunities Drivers - 2007-2012
• 8.5. Decontamination - U. S. Federal HLS R&D Funding Opportunities Inhibitors - 2007-2012
• 8.6. DHS - Decontamination HLS R&D Programs
  • 8.6.1. Response and Recovery
  • 8.6.2. Decontamination of Porous Surfaces After a Radiological Attack
  • 8.6.3. Expedient Mitigation of a Radiological Release
• 8.7. DARPA (DOD) - Decontamination HLS R&D Programs
  • 8.7.1. Immune Buildings
  • 8.7.2. External Protection
• 8.8. CBDP (DOD) - Decontamination HLS R&D Programs
  • 8.8.1. Project CB1 - Decontamination
  • 8.8.2. Project CB2 - Decontamination
  • 8.8.3. Project CB3 Biological Defense (ATD) - Decontamination
  • 8.8.4. Project DE4 Decontamination Systems (ACD&P)
  • 8.8.5. Project DE5 Decontamination Systems (SDD)
• 8.9. ARMY (DOD) - Decontamination HLS R&D Programs
  • 8.9.1. Environmental Quality Technology
• 8.10. DOE - Decontamination HLS R&D Programs
  • 8.10.1. Environmental Remediation Science Research
• 8.11. EPA - Decontamination HLS R&D Programs
  • 8.11.1. Water Infrastructure Decontamination
  • 8.11.2. Threat and Consequence Assessment
  • 8.11.3. Nonstandard Methods
  • 8.11.4. Decontamination for Buildings, Large Structures, and Outdoor Areas
  • 8.11.5. Toxicity, Infectivity, and Mechanism of Action
• 8.12. TSWG - Decontamination HLS R&D Programs
  • 8.12.1. Statistical Design Tool for Sampling Contaminated Buildings
  • 8.12.2. Decontamination

9. Vendors

• 9.1. Vendors and Products

10. Patent Review

• 10.1. Scope
• 10.2. Decontamination Technology Patents

11. Decontamination - Legal Issues

• 11.1. International / European Legislation/Agreements
  • 11.1.1. The Nuclear Weapons Non-Proliferation Treaty (NPT) - 1970
  • 11.1.2. The Biological and Toxin Weapons Convention (BTWC) - 1972
  • 11.1.3. Convention for the Physical Protection of Nuclear Material - 1987
  • 11.1.4. Chemicals Weapons Convention - 1992
• 11.2. U.S. Legislation
  • 11.2.1. U.S. Code Title 50, Chapter 40 - Defense Against Weapons of Mass Destruction
  • 11.2.2. Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA) - 1996
  • 11.2.3. Emergency Supplemental Appropriations Act for Recovery from and Response to Terrorist Attacks on the United States - 2001
  • 11.2.4. Public Health Security and Bioterrorism Preparedness and Response Act - 2002